Robert B. Kay
2017
In 2017, Robert B. Kay earned a total compensation of $417.8K as Executive Chairman at iBio, a 47% decrease compared to previous year.
Compensation breakdown
| Option Awards | $107,085 |
|---|---|
| Salary | $310,732 |
| Total | $417,817 |
Kay received $310.7K in salary, accounting for 74% of the total pay in 2017.
Kay also received $107.1K in option awards.
Rankings
In 2017, Robert B. Kay's compensation ranked 12,485th out of 14,666 executives tracked by ExecPay. In other words, Kay earned more than 14.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,485 out of 14,666 | 15th |
Division Manufacturing | 4,909 out of 5,770 | 15th |
Major group Chemicals And Allied Products | 1,795 out of 2,074 | 14th |
Industry group Drugs | 1,493 out of 1,730 | 14th |
Industry Pharmaceutical Preparations | 1,154 out of 1,329 | 13th |
Source: SEC filing on November 27, 2017.
Kay's colleagues
We found four more compensation records of executives who worked with Robert B. Kay at iBio in 2017.